return2ozma@lemmy.world to News@lemmy.world · 11 个月前Ozempic maker Novo Nordisk facing pressure as study finds $1,000 appetite suppressant can be made for just $5fortune.comexternal-linkmessage-square158fedilinkarrow-up1617arrow-down117cross-posted to: [email protected][email protected][email protected][email protected][email protected][email protected][email protected][email protected]
arrow-up1600arrow-down1external-linkOzempic maker Novo Nordisk facing pressure as study finds $1,000 appetite suppressant can be made for just $5fortune.comreturn2ozma@lemmy.world to News@lemmy.world · 11 个月前message-square158fedilinkcross-posted to: [email protected][email protected][email protected][email protected][email protected][email protected][email protected][email protected]
minus-squareCornelius_Wangenheim@lemmy.worldlinkfedilinkarrow-up6·edit-211 个月前You forgot the biggest expense; the billions of dollars in stock buybacks.
You forgot the biggest expense; the billions of dollars in stock buybacks.